The Branchburg Operations Campus has successfully completed a major facility expansion that significantly enhances Roche Diagnostics’ manufacturing, logistics, and utility infrastructure while advancing long-term sustainability and carbon-reduction objectives. Officially opened on November ‘24, the expansion represents a pivotal investment in the site’s future capacity, resilience, and global impact.

The project delivered  a 75,000-square-foot operations building and  a 95,000-square-foot on-campus warehouse, consolidating previously off-site logistics functions and enabling more efficient, scalable operations. The new operations building supports reagent packaging and labeling for key diagnostic platforms, including the Molecular Labs Customer Area (GenMark) and Near Patient Care products (cobas® Liat), strengthening Branchburg’s role as North America’s largest diagnostic operations site.

To support long-term growth while safeguarding future development flexibility, the project also included construction of a 9,000-square-foot Central Utility Plant (CUP) with an adjacent Thermal Energy Storage (TES) system, which also acts as a dedicated fire protection backup tank.
This infrastructure expansion increases site utility capacity, improves operational redundancy, and ensures that underground utilities are strategically planned to avoid conflicts with future campus development.

Sustainability was a core design and delivery principle throughout the project. As part of Roche’s CO₂ reduction roadmap and commitment to achieving Real Zero greenhouse gas emissions by 2050, the expansion incorporated award-winning geothermal technology beneath the warehouse foundation. This approach enables the site to add significant new operational capacity with no net increase in total site emissions, marking the first U.S. DIA campus to implement geothermal technology at this scale.

Beyond its physical footprint, the project represents a strategic enabler for Roche’s global diagnostics network—enhancing supply chain efficiency, supporting workforce growth, improving the employee environment, and increasing the site’s ability to deliver innovative, life-saving diagnostic solutions worldwide.

Together, these investments position the Branchburg campus for its next chapter of growth, ensuring operational excellence, environmental leadership, and long-term value creation for Roche, its patients, and its global customer base.

Concept Architect: Barkow Leibinger, Berlin 2024